The signal
On 26 October 2026, Western Australia formally adopted the federal Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 as state law under the Therapeutic Goods Law Application Act 2024.
Who should care
Healthcare providers, therapeutic goods manufacturers, and compliance officers in WA must review their product formulations and regulatory compliance frameworks promptly to ensure alignment with the updated permissible ingredients rules.
What changed
The WA government published the Therapeutic Goods (Legislative Instruments) Notice (No. 18) 2026, which brings the federal Determination (No. 3) 2026 on permissible ingredients for therapeutic goods into effect as state law. This legislative instrument updates the list of approved and prohibited ingredients for therapeutic goods in WA, reflecting changes made at the federal level and applying them within the state jurisdiction.
Want to follow this thread yourself? Search GovScanner's free dashboard, or connect GovScanner to your favourite AI so your model can explore WA government data for you.
Why it matters
This legal adoption means therapeutic goods supplied or manufactured in WA must comply with the updated ingredients standards. Non-compliance risks regulatory action, delays in product approvals, and potential market withdrawal. Manufacturers need to reassess formulations, labelling, and supply chains to avoid penalties and ensure continued access to the WA market. Healthcare providers should also verify that the therapeutic products they dispense or prescribe meet the new ingredient requirements to maintain patient safety and regulatory compliance.
Source trail
The formal adoption was documented in the Therapeutic Goods (Legislative Instruments) Notice (No. 18) 2026. This Notice references the federal Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (hosted on the Federal Register of Legislation), which sets out specific ingredient permissions and prohibitions. The WA enactment is pursuant to the Therapeutic Goods Law Application Act 2024, which enables such federal instruments to operate as WA law.
Watch next
Stakeholders should monitor for any supplementary guidance or compliance checklists from the WA Department of Health or the Minister for Health, who administers the Therapeutic Goods Law Application Act 2024. Additionally, watch for any amendments or clarifications to the permissible ingredients list, particularly during the next state parliamentary sitting or federal updates. Compliance officers should also track related licensing or registration deadlines that may arise from these changes.
Find your own data
Want to explore this thread yourself? Search the free GovScanner dashboard, or connect GovScanner directly to your favourite AI so your model can investigate WA government data for you. It is quick to connect, and it gives your AI raw access to structured WA government records instead of making it hunt through PDFs and webpages from scratch.
